Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ. Pfaller MA, et al. Among authors: tendolkar s. J Clin Microbiol. 2007 Jan;45(1):70-5. doi: 10.1128/JCM.01551-06. Epub 2006 Nov 1. J Clin Microbiol. 2007. PMID: 17079501 Free PMC article.
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.
Pfaller MA, Messer SA, Boyken L, Hollis RJ, Rice C, Tendolkar S, Diekema DJ. Pfaller MA, et al. Among authors: tendolkar s. Diagn Microbiol Infect Dis. 2004 Mar;48(3):201-5. doi: 10.1016/j.diagmicrobio.2003.09.008. Diagn Microbiol Infect Dis. 2004. PMID: 15023430
Further standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates.
Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ. Pfaller MA, et al. Among authors: tendolkar s. J Clin Microbiol. 2004 Jul;42(7):3117-9. doi: 10.1128/JCM.42.7.3117-3119.2004. J Clin Microbiol. 2004. PMID: 15243069 Free PMC article.
Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp.
Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ. Pfaller MA, et al. Among authors: tendolkar s. J Clin Microbiol. 2004 Jul;42(7):3137-41. doi: 10.1128/JCM.42.7.3137-3141.2004. J Clin Microbiol. 2004. PMID: 15243072 Free PMC article.
Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.
Pfaller MA, Messer SA, Boyken L, Tendolkar S, Hollis RJ, Diekema DJ. Pfaller MA, et al. Among authors: tendolkar s. J Clin Microbiol. 2004 Jul;42(7):3142-6. doi: 10.1128/JCM.42.7.3142-3146.2004. J Clin Microbiol. 2004. PMID: 15243073 Free PMC article.
48 results